Pay in 4 interest-free payments of $5.19 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Retatrutide is an investigational triple agonist (GLP-1, GIP, glucagon) peptide injectable not yet licensed by the MHRA or EMA
DONT STOP USING THEM
Research showed that weight regain is common after discontinuing semaglutide (a common GLP-1 medication), with people regaining two-thirds of the weight they lost, and improvements in risk factors like blood pressure and HbA1c also reversed
Snchez-Martnez R, Cruz-Gil S, Gmez de Cedrn M, lvarez-Fernndez M, Vargas T, Molina S, et al
US$ 28.10
US$ 23.39
US$ 20.96
US$ 28.23
US$ 27.37
US$ 25.90
US$ 29.66
